Dose-escalating Safety Study in Subjects on Stable Statin Therapy

NCT00231569 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: ISIS 301012 or Placebo
DRUG: ISIS 301012 or Placebo
DRUG: ISIS 301012 or Placebo
DRUG: ISIS 301012 or Placebo
DRUG: ISIS 301012 or Placebo
DRUG: ISIS 301012 or Placebo
DRUG: ISIS 301012 or Placebo

Sponsor

Kastle Therapeutics, LLC

Collaborators

[object Object]